Paul M. Coplan, MS, ScD, MBA
|CCEB Appointment||Adjunct Scholar, Epidemiology|
|Adjunct DBE Appointment||Adjunct Assistant Professor of Epidemiology|
|Non-Penn Appointment||Executive Director, Risk Management and Epidemiology|
Purdue Pharma L.P.
Coplan PM, Mitchnick M, Rosenberg ZF. Public health. Regulatory challenges in microbicide development. Science 2004; 304:1911-1912.
Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, Mbewe B, et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 2005; 191:1427-1434.
Coplan PM, Cook JR, Carides GW, Heyse JF, Wu AW, Hammer SM, et al. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Clin Infect Dis 2004; 39:426-433.
Coplan PM, Nikas A, Japour A, Cormier K, Maradit-Kremers H, Lewis R, et al. Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors. AIDS Res Hum Retroviruses 2003; 19:449-455.
Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344:327-332